Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Angiotensinogen and interleukin-18 as markers of chronic kidney damage in children with a history of hemolytic uremic syndrome

K. Lipiec, P. Adamczyk, E. Świętochowska, K. Ziora, M. Szczepańska

. 2017 ; 66 (2) : 251-261. [pub] 20161216

Language English Country Czech Republic

Document type Journal Article

Hemolytic uremic syndrome (HUS) is a type of thrombotic microangiopathy, in the course of which some patients may develop chronic kidney disease (CKD). It is clinically important to investigate the markers of a poor prognosis. The levels of angiotensinogen (AGT) and interleukin-18 (IL-18) in serum and urine were evaluated. Study was conducted in 29 children with a history of HUS. Serum and urine AGT concentration was significantly higher in children after HUS as compared to the control group. No differences depending on the type of HUS and gender were noted. The serum concentration of IL-18 in children after HUS was significantly lower, whereas in urine did not differ significantly between the sick and healthy children. A negative correlation between the concentration of AGT in serum and albuminuria in patients after HUS was detected. The results indicate that the concentration of AGT in serum and urine in children after HUS increases, which may indicate the activation of the intrarenal renin-angiotensin-aldosterone system. The statement, that AGT may be a good biomarker of CKD after acute kidney injury due to HUS requires prospective studies with follow-up from the acute phase of the disease on a larger group of patients. Reduced IL-18 serum concentration in children after HUS with no difference in its urine concentration may indicate a loss of the protective effects of this cytokine on renal function due to previously occurred HUS.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011452
003      
CZ-PrNML
005      
20180502083259.0
007      
ta
008      
180405s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933340 $2 doi
035    __
$a (PubMed)27982687
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Lipiec, K $u Department of Pediatric Nephrology with Dialysis Division for Children, Zabrze, Poland
245    10
$a Angiotensinogen and interleukin-18 as markers of chronic kidney damage in children with a history of hemolytic uremic syndrome / $c K. Lipiec, P. Adamczyk, E. Świętochowska, K. Ziora, M. Szczepańska
520    9_
$a Hemolytic uremic syndrome (HUS) is a type of thrombotic microangiopathy, in the course of which some patients may develop chronic kidney disease (CKD). It is clinically important to investigate the markers of a poor prognosis. The levels of angiotensinogen (AGT) and interleukin-18 (IL-18) in serum and urine were evaluated. Study was conducted in 29 children with a history of HUS. Serum and urine AGT concentration was significantly higher in children after HUS as compared to the control group. No differences depending on the type of HUS and gender were noted. The serum concentration of IL-18 in children after HUS was significantly lower, whereas in urine did not differ significantly between the sick and healthy children. A negative correlation between the concentration of AGT in serum and albuminuria in patients after HUS was detected. The results indicate that the concentration of AGT in serum and urine in children after HUS increases, which may indicate the activation of the intrarenal renin-angiotensin-aldosterone system. The statement, that AGT may be a good biomarker of CKD after acute kidney injury due to HUS requires prospective studies with follow-up from the acute phase of the disease on a larger group of patients. Reduced IL-18 serum concentration in children after HUS with no difference in its urine concentration may indicate a loss of the protective effects of this cytokine on renal function due to previously occurred HUS.
650    _2
$a mladiství $7 D000293
650    _2
$a angiotensinogen $x krev $x metabolismus $x moč $7 D000808
650    _2
$a biologické markery $x krev $x moč $7 D015415
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hemolyticko-uremický syndrom $x diagnóza $x metabolismus $7 D006463
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a interleukin-18 $x krev $x metabolismus $x moč $7 D020382
650    _2
$a chronické selhání ledvin $x diagnóza $x metabolismus $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
700    1_
$a Adamczyk, P. $u Department and Clinic of Pediatrics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice,Zabrze, Poland
700    1_
$a Świętochowska, E. $u Chair and Department of Medical and Molecular Biology, School of Medicine with the Division of Dentistry in Zabrze,Medical University of Silesia in Katowice, Zabrze, Poland
700    1_
$a Ziora, K. $u Department and Clinic of Pediatrics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice,Zabrze, Poland
700    1_
$a Szczepańska, M. $u Department and Clinic of Pediatrics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice,Zabrze, Poland
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 2 (2017), s. 251-261
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27982687 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20180405 $b ABA008
991    __
$a 20180425135612 $b ABA008
999    __
$a ok $b bmc $g 1296231 $s 1008264
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c 2 $d 251-261 $e 20161216 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20180405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...